(Q52148894)

English

Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier.

scientific article published on 11 September 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/26402114

Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier. (English)

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/26402114

blood–brain barrier

1 reference

based on heuristic

inferred from title

Fabien Gosselet

8

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/26402114

Laurence Fenart

object named as

Laurence Fenart

7

0 references

author name string

Mélanie Kuntz

1

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/26402114

Pietra Candela

2

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/26402114

Julien Saint-Pol

3

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/26402114

Yordenca Lamartinière

4

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/26402114

Marie-Christine Boucau

5

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/26402114

Emmanuel Sevin

6

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/26402114

publication date

11 September 2015

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/26402114

Journal of Alzheimer's Disease

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/26402114

48

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/26402114

3

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/26402114

849-862

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/26402114

copyright license

Creative Commons Attribution-NonCommercial 4.0 International

1 October 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Alzheimer's disease: the amyloid cascade hypothesis

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Cholesterol metabolism, apolipoprotein E, adenosine triphosphate-binding cassette transporters, and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

The role of ATP-binding cassette transporter A1 in Alzheimer's disease and neurodegeneration

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein/presenilin 1 mice

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Comment on "ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models"

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models".

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Comment on "ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models"

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

In vivo measurement of apolipoprotein E from the brain interstitial fluid using microdialysis

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models".

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

The emerging role of bexarotene in the treatment of Alzheimer's disease: current evidence

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Amyloid-β peptides, Alzheimer's disease and the blood-brain barrier.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

The blood-brain barrier in health and chronic neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Modelling of the blood-brain barrier in drug discovery and development.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Oxysterols decrease apical-to-basolateral transport of Aß peptides via an ABCB1-mediated process in an in vitro Blood-brain barrier model constituted of bovine brain capillary endothelial cells.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

ABCA1 and scavenger receptor class B, type I, are modulators of reverse sterol transport at an in vitro blood-brain barrier constituted of porcine brain capillary endothelial cells

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Peripheral reduction of β-amyloid is sufficient to reduce brain β-amyloid: implications for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Cerebral amyloid-β proteostasis is regulated by the membrane transport protein ABCC1 in mice

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Accumulation of murine amyloid-β mimics early Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

A stable and reproducible human blood-brain barrier model derived from hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Improved survival, vascular differentiation and wound healing potential of stem cells co-cultured with endothelial cells

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Modelling the neurovascular unit and the blood-brain barrier with the unique function of pericytes.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Regulatory effects of synthetic liver X receptor- and peroxisome-proliferator activated receptor agonists on sterol transport pathways in polarized cerebrovascular endothelial cells

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Transcriptional profiles of receptors and transporters involved in brain cholesterol homeostasis at the blood-brain barrier: use of an in vitro model.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

P-glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-beta

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Intercommunications between brain capillary endothelial cells and glial cells increase the transcellular permeability of the blood-brain barrier during ischaemia.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Effects of oxysterols on the blood-brain barrier: implications for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Reversal of apoE4-driven brain pathology and behavioral deficits by bexarotene.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Altered cerebral vascular volumes and solute transport at the blood-brain barriers of two transgenic mouse models of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Expression of nuclear receptor mRNA and liver X receptor-mediated regulation of ABC transporter A1 at rat blood-brain barrier

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Purification and ATPase activity of human ABCA1.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Molecular interactions between apoE and ABCA1: impact on apoE lipidation

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

24S-hydroxycholesterol induces cholesterol release from choroid plexus epithelial cells in an apical- and apoE isoform-dependent manner concomitantly with the induction of ABCA1 and ABCG1 expression

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Specific loss of brain ABCA1 increases brain cholesterol uptake and influences neuronal structure and function

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Bexarotene reduces blood-brain barrier permeability in cerebral ischemia-reperfusion injured rats

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Retinoic acid isomers facilitate apolipoprotein E production and lipidation in astrocytes through the retinoid X receptor/retinoic acid receptor pathway

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Stimulation of the retinoid X receptor facilitates beta-amyloid clearance across the blood-brain barrier

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Cholesterol modulates P-glycoprotein activity in human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

ABCB1, ABCC1, and LRP gene expressions are altered by LDL, HDL, and serum deprivation in a human doxorubicin-resistant uterine sarcoma cell line.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Liver X receptor activation enhances blood-brain barrier integrity in the ischemic brain and increases the abundance of ATP-binding cassette transporters ABCB1 and ABCC1 on brain capillary cells.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Role of LXR and ABCA1 in the pathogenesis of Alzheimer's disease - implications for a new therapeutic approach.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

In vitro model for evaluating drug transport across the blood-brain barrier

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

The RXR Agonist Bexarotene Improves Cholesterol Homeostasis and Inhibits Atherosclerosis Progression in a Mouse Model of Mixed Dyslipidemia

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150469

21 January 2018

Identifiers

10.3233/JAD-150469

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/26402114

1 reference

Europe PubMed Central

23 April 2018

http://europepmc.org/abstract/MED/26402114

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52148894&oldid=1854888209"